相关实验视频

Updated: Sep 18, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

解锁质母细胞瘤:分子机制和下一代疗法的突破

Fariah Rizwani¹, Pallavi Patil¹, Khush Jain²

¹Department of Pharmacology, Bharati Vidyapeeth College of Pharmacy, University of Mumbai, Mumbai, India.

Medical oncology (Northwood, London, England)

|June 21, 2025

概括

质母细胞瘤 (GB) 是一种具有攻击性的脑瘤. 像免疫疗法和纳米技术这样的新疗法为改善患者生存和治疗策略提供了新的希望.

科学领域:

神经瘤学神经瘤学
分子生物学分子生物学
遗传学遗传学是一种遗传学.

背景情况:

质母细胞瘤 (GB) 是成年人中最具攻击性的原发性脑瘤,其特征是快速进展和对标准治疗的耐药性.
目前GB的生存率仍然很低,尽管手术,放射和化疗的进展.

研究的目的:

提供关于质母细胞瘤分子格局,病理机制,流行病学和创新的治疗策略的全面审查.
综合当前的研究,并突出未来的方向,以彻底改变GB治疗和改善患者的结果.

主要方法:

对质母细胞瘤的分子分类,病理机制和流行病学的审查.
分析新兴的治疗策略,包括免疫疗法,纳米技术和向抑制剂.
对16项临床试验的系统审查,这些试验涉及结合治疗质母细胞瘤的组合策略.

主要成果:

信号通路中的关键遗传突变 (例如TP53,MAPK/ERK,PI3K/AKT/mTOR) 驱动GB的进展,耐药性和免疫逃避.
诊断 (成像,分子分析) 的进步提高了早期检测和个性化治疗.
免疫疗法,基于纳米技术的药物输送和向抑制剂等新的方法显示出超越传统治疗的前景.

结论:

新兴的组合策略对于优化质母细胞瘤管理至关重要,目前正在进行的研究重点是改善患者的生存率.
质母细胞瘤治疗的未来方向有可能显著改善这种具有挑战性的疾病患者的治疗结果.

关键词:

质母细胞瘤 (glioblastoma) 是一个免疫治疗是一种免疫疗法.系统性审查系统性审查有针对性的治疗.治疗耐药性是一种治疗性耐药性.瘤微环境是一个微环境.

更多相关视频

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.